查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1748721

診斷皮膚病學影像設備市場—全球產業規模、佔有率、趨勢、機會和預測（按模式、按應用、按最終用戶、按地區和競爭細分，2020-2030 年）

Diagnostic Dermatology Imaging Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球診斷皮膚病影像設備市場價值為 51.3 億美元，預計到 2030 年將達到 89.1 億美元，複合年成長率為 9.62%。皮膚病患病率的不斷上升以及對準確、早期和非侵入性診斷工具的需求推動了市場的成長。隨著皮膚癌（尤其是黑色素瘤）對全球健康的威脅日益嚴重，對支持早期發現和有效管理的先進影像技術的需求也日益增加。患者對定期皮膚評估的認知不斷提高，也促使醫療保健提供者採用創新的診斷設備。此外，人口老化和與生活方式相關的皮膚病（如痤瘡、濕疹和牛皮癬）正在推動進一步的需求。影響市場的一個主要趨勢是將人工智慧 (AI) 和機器學習整合到皮膚病學平台中，從而實現自動分析並提高診斷精度。行動、人工智慧和基於雲端的成像系統的日益普及正在提高皮膚科實踐的可及性、簡化診斷並促進遠端護理能力。

市場概覽
預測期 2026-2030
2024年市場規模 51.3億美元
2030年市場規模 89.1億美元
2025-2030 年複合年成長率 9.62%
成長最快的領域 傷口和潰瘍評估
最大的市場 北美洲

關鍵市場促進因素

皮膚病和皮膚癌發生率上升

主要市場挑戰

先進成像系統成本高昂

主要市場趨勢

遠距皮膚病學和遠端診斷的發展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球診斷皮膚病學影像設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按模式（先進診斷影像設備、表面視覺化設備、切片設備、分子診斷設備和平台）
    • 按應用（皮膚癌、發炎和自體免疫性皮膚病、感染性皮膚病、傷口和潰瘍評估）
    • 按最終使用者（醫院、皮膚科診所/中心、癌症中心/腫瘤科診所、其他）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美診斷皮膚病學影像設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲診斷皮膚病學影像設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區診斷皮膚病學影像設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲診斷皮膚病學影像設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲診斷皮膚病學影像設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Canfield Scientific
  • Caliber Imaging & Diagnostics
  • Michelson Diagnostics (MDL)
  • SciBase AB
  • DermaSensor Inc.
  • Damae Medical
  • Apollo Medical Optics
  • Enspectra Health, Inc.
  • Dermavision Solutions
  • Dermus Ltd.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29597

The Global Diagnostic Dermatology Imaging Devices Market was valued at USD 5.13 Billion in 2024 and is projected to reach USD 8.91 Billion by 2030, registering a CAGR of 9.62%. Market growth is being propelled by the increasing prevalence of skin conditions and the need for accurate, early, and non-invasive diagnostic tools. With skin cancer, especially melanoma, posing a growing global health threat, there is heightened demand for advanced imaging technologies that support early detection and effective management. Rising patient awareness regarding regular skin evaluations is also prompting healthcare providers to adopt innovative diagnostic equipment. In addition, an aging population and lifestyle-related skin disorders such as acne, eczema, and psoriasis are driving further demand. A major trend shaping the market is the integration of artificial intelligence (AI) and machine learning into dermatology platforms, enabling automated analysis and enhanced diagnostic precision. The growing popularity of mobile, AI-enabled, and cloud-based imaging systems is improving accessibility, streamlining diagnosis, and fostering remote care capabilities in dermatology practices.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.13 Billion
Market Size 2030USD 8.91 Billion
CAGR 2025-20309.62%
Fastest Growing SegmentWound & Ulcer Assessment
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Skin Disorders and Skin Cancer

The growing global incidence of skin disorders and skin cancer is a major driver for the increased use of diagnostic dermatology imaging devices. In the United States alone, skin cancer remains the most commonly diagnosed cancer, with an estimated 5.4 million cases reported annually. CDC data further highlights that more than 6.1 million adults are treated each year for basal and squamous cell carcinomas, incurring nearly USD 8.9 billion in treatment costs. Melanoma, while less prevalent, is notably aggressive, with approximately 200,340 cases projected in 2024, including 99,700 in situ and 100,640 invasive cases. Traditional assessment methods-such as manual examination-lack the depth and precision required for early detection. Devices like dermatoscopes, reflectance confocal microscopes, and optical coherence tomography provide non-invasive, real-time, cellular-level imaging, enhancing diagnostic accuracy and enabling earlier intervention. This contributes to significantly improved survival outcomes, as early-stage melanoma carries a five-year relative survival rate exceeding 94%.

Key Market Challenges

High Cost of Advanced Imaging Systems

The elevated cost of advanced imaging systems presents a significant obstacle to the broader adoption of diagnostic dermatology devices. Technologies such as high-resolution digital dermatoscopes, reflectance confocal microscopes, and optical coherence tomography scanners involve substantial initial investment. Smaller healthcare providers and facilities in under-resourced areas often struggle with the financial burden of procuring, maintaining, and upgrading this equipment. Additionally, ongoing expenses related to software updates, technical servicing, and clinician training further strain budgets. These financial limitations restrict the availability of advanced diagnostic tools in rural or low-income regions, thereby impeding timely diagnosis and treatment for underserved populations.

Key Market Trends

Growth of Teledermatology and Remote Diagnostics

A key trend reshaping the Global Diagnostic Dermatology Imaging Devices Market is the growing emphasis on teledermatology and remote diagnostic capabilities. The need for accessible skin healthcare in rural and underserved areas has spurred the development of compact, cloud-enabled imaging tools that facilitate real-time skin assessments and virtual consultations. These platforms allow patients to securely send high-resolution images of skin lesions to dermatologists, enabling remote analysis and timely diagnosis. This model improves convenience for patients and enhances dermatologists' efficiency by streamlining triage and reducing the need for in-person visits. Rising smartphone use and broader internet access further support the adoption of mobile imaging technologies, making them valuable instruments in expanding early diagnostic coverage.

Report Scope:

In this report, the Global Diagnostic Dermatology Imaging Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Dermatology Imaging Devices Market, By Modality:

  • Advanced Diagnostic Imaging Devices
  • Surface Visualization Devices
  • Biopsy Devices
  • Molecular Diagnostic Devices & Platforms

Diagnostic Dermatology Imaging Devices Market, By Application:

  • Skin Cancer
  • Inflammatory & Autoimmune Skin Diseases
  • Infectious Skin Conditions
  • Wound & Ulcer Assessment

Diagnostic Dermatology Imaging Devices Market, By End User:

  • Hospitals
  • Dermatology Clinics/Centers
  • Cancer Centers/Oncology Clinics
  • Others

Diagnostic Dermatology Imaging Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Dermatology Imaging Devices Market.

Available Customizations:

Global Diagnostic Dermatology Imaging Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Diagnostic Dermatology Imaging Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Modality (Advanced Diagnostic Imaging Devices, Surface Visualization Devices, Biopsy Devices, Molecular Diagnostic Devices & Platforms)
    • 5.2.2. By Application (Skin Cancer, Inflammatory & Autoimmune Skin Diseases, Infectious Skin Conditions, Wound & Ulcer Assessment)
    • 5.2.3. By End User (Hospitals, Dermatology Clinics/Centers, Cancer Centers/Oncology Clinics, Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Diagnostic Dermatology Imaging Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Modality
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diagnostic Dermatology Imaging Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Modality
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Mexico Diagnostic Dermatology Imaging Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Modality
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Canada Diagnostic Dermatology Imaging Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Modality
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Diagnostic Dermatology Imaging Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Modality
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Diagnostic Dermatology Imaging Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Modality
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Diagnostic Dermatology Imaging Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Modality
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Diagnostic Dermatology Imaging Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Modality
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Diagnostic Dermatology Imaging Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Modality
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Diagnostic Dermatology Imaging Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Modality
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Diagnostic Dermatology Imaging Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Modality
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Diagnostic Dermatology Imaging Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Modality
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Diagnostic Dermatology Imaging Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Modality
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. South Korea Diagnostic Dermatology Imaging Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Modality
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Japan Diagnostic Dermatology Imaging Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Modality
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Diagnostic Dermatology Imaging Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Modality
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Diagnostic Dermatology Imaging Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Modality
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Diagnostic Dermatology Imaging Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Modality
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Diagnostic Dermatology Imaging Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Modality
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Diagnostic Dermatology Imaging Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Modality
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Diagnostic Dermatology Imaging Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Modality
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Diagnostic Dermatology Imaging Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Modality
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Diagnostic Dermatology Imaging Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Modality
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Diagnostic Dermatology Imaging Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Modality
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Canfield Scientific
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Caliber Imaging & Diagnostics
  • 15.3. Michelson Diagnostics (MDL)
  • 15.4. SciBase AB
  • 15.5. DermaSensor Inc.
  • 15.6. Damae Medical
  • 15.7. Apollo Medical Optics
  • 15.8. Enspectra Health, Inc.
  • 15.9. Dermavision Solutions
  • 15.10. Dermus Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer